Biomerica Stock Total Debt

BMRA Stock  USD 0.73  0.03  3.95%   
Biomerica fundamentals help investors to digest information that contributes to Biomerica's financial success or failures. It also enables traders to predict the movement of Biomerica Stock. The fundamental analysis module provides a way to measure Biomerica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biomerica stock.
The current year's Total Debt To Capitalization is expected to grow to 0.24.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Biomerica Company Total Debt Analysis

Biomerica's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Total Debt

 = 

Bonds

+

Notes

More About Total Debt | All Equity Analysis

Current Biomerica Total Debt

    
  785 K  
Most of Biomerica's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biomerica is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Biomerica Total Debt Driver Correlations

Understanding the fundamental principles of building solid financial models for Biomerica is extremely important. It helps to project a fair market value of Biomerica Stock properly, considering its historical fundamentals such as Total Debt. Since Biomerica's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Biomerica's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Biomerica's interrelated accounts and indicators.
0.97-0.81-0.520.20.890.990.310.12-0.090.490.86-0.040.880.83-0.01-0.540.950.950.58
0.97-0.8-0.340.260.770.970.320.06-0.070.320.75-0.070.80.710.16-0.410.910.910.42
-0.81-0.80.350.26-0.7-0.86-0.14-0.43-0.3-0.31-0.54-0.38-0.66-0.54-0.010.29-0.75-0.76-0.47
-0.52-0.340.350.12-0.73-0.50.10.10.39-0.96-0.680.22-0.72-0.820.490.71-0.57-0.55-0.93
0.20.260.260.120.040.130.44-0.5-0.43-0.050.25-0.550.120.070.14-0.170.250.26-0.21
0.890.77-0.7-0.730.040.880.340.25-0.080.640.860.040.850.94-0.09-0.730.820.810.71
0.990.97-0.86-0.50.130.880.320.17-0.030.470.820.030.870.810.0-0.540.940.940.57
0.310.32-0.140.10.440.340.320.0-0.16-0.110.15-0.150.050.190.29-0.490.280.3-0.22
0.120.06-0.430.1-0.50.250.170.00.88-0.150.110.88-0.010.04-0.030.090.020.020.0
-0.09-0.07-0.30.39-0.43-0.08-0.03-0.160.88-0.4-0.190.95-0.16-0.270.050.46-0.2-0.2-0.2
0.490.32-0.31-0.96-0.050.640.47-0.11-0.15-0.40.69-0.250.710.76-0.67-0.680.60.580.91
0.860.75-0.54-0.680.250.860.820.150.11-0.190.69-0.140.850.85-0.34-0.590.880.860.66
-0.04-0.07-0.380.22-0.550.040.03-0.150.880.95-0.25-0.14-0.04-0.14-0.030.32-0.15-0.15-0.02
0.880.8-0.66-0.720.120.850.870.05-0.01-0.160.710.85-0.040.9-0.24-0.510.840.830.83
0.830.71-0.54-0.820.070.940.810.190.04-0.270.760.85-0.140.9-0.16-0.730.770.750.83
-0.010.16-0.010.490.14-0.090.00.29-0.030.05-0.67-0.34-0.03-0.24-0.160.17-0.2-0.19-0.5
-0.54-0.410.290.71-0.17-0.73-0.54-0.490.090.46-0.68-0.590.32-0.51-0.730.17-0.61-0.6-0.54
0.950.91-0.75-0.570.250.820.940.280.02-0.20.60.88-0.150.840.77-0.2-0.611.00.57
0.950.91-0.76-0.550.260.810.940.30.02-0.20.580.86-0.150.830.75-0.19-0.61.00.55
0.580.42-0.47-0.93-0.210.710.57-0.220.0-0.20.910.66-0.020.830.83-0.5-0.540.570.55
Click cells to compare fundamentals

Biomerica Total Debt Historical Pattern

Today, most investors in Biomerica Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Biomerica's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Biomerica total debt as a starting point in their analysis.
   Biomerica Total Debt   
       Timeline  
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Competition

Biomerica Net Debt

Net Debt

(2.89 Million)

At present, Biomerica's Net Debt is projected to decrease significantly based on the last few years of reporting.
Based on the latest financial disclosure, Biomerica has a Total Debt of 785 K. This is 99.97% lower than that of the Health Care Equipment & Supplies sector and 99.96% lower than that of the Health Care industry. The total debt for all United States stocks is 99.99% higher than that of the company.

Biomerica Total Debt Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biomerica's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biomerica could also be used in its relative valuation, which is a method of valuing Biomerica by comparing valuation metrics of similar companies.
Biomerica is currently under evaluation in total debt category among its peers.

Biomerica Current Valuation Drivers

We derive many important indicators used in calculating different scores of Biomerica from analyzing Biomerica's financial statements. These drivers represent accounts that assess Biomerica's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Biomerica's important valuation drivers and their relationship over time.
202020212022202320242025 (projected)
Market Cap43.5M44.4M19.4M9.8M8.8M10.3M
Enterprise Value41.0M39.8M10.8M6.4M5.7M9.1M

Biomerica Institutional Holders

Institutional Holdings refers to the ownership stake in Biomerica that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Biomerica's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Biomerica's value.
Shares
Xtx Topco Ltd2024-12-31
19.2 K
Virtu Financial Llc2024-12-31
17.8 K
Raymond James Finl Svs Advisors, Inc.2024-09-30
14.5 K
Hollencrest Securities, Llc2024-12-31
11.6 K
Cambridge Invest Research Advisors, Inc.2024-12-31
10.1 K
Atlantic Trust Group, Llc2024-09-30
2.6 K
Harbour Investments, Inc.2024-12-31
1000
Atala Financial Inc2024-12-31
500
Bank Of America Corp2024-12-31
328
Granahan Investment Management Inc..2024-12-31
658.8 K
Vanguard Group Inc2024-12-31
169 K

Biomerica Fundamentals

About Biomerica Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Biomerica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biomerica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biomerica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Biomerica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomerica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomerica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomerica Stock:
Check out Biomerica Piotroski F Score and Biomerica Altman Z Score analysis.
For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.37)
Revenue Per Share
0.327
Quarterly Revenue Growth
0.055
Return On Assets
(0.39)
Return On Equity
(0.76)
The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.